JESSICA SALAZAR: Open Payments
NPI 1679906077 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 12 payments from 10 companies in 2025. Trend: 2023 $148 · 2024 $488 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Medtronic, Inc. | 1 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: AIRSUPRA, SAPIEN 3 Ultra RESILIA, INCEPTIV, TZIELD, Kerendia, ENTYVIO, Dexcom G6 Transmitter, Wegovy.
Industry payments across TX — which companies pay providers there.
